Monitoring of patients with rheumatoid arthritis by indocyanine green (ICG)-enhanced fluorescence optical imaging treated with anti-TNFα therapy

BACKGROUND: Fluorescence optical imaging (FOI) enables visualisation of inflammation in both hands in rheumatoid arthritis (RA). OBJECTIVE: To investigate the usefulness of FOI in treatment monitoring under anti-TNFα therapy with certolizumab pegol (CZP) in patients with RA in comparison to clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hertrampf, S., Klotsche, J., Schefer, Q., Glimm, A. M., Burmester, G. R., Hoff, P., Schmittat, G., Häupl, T., Hermann, S., Backhaus, M., Ohrndorf, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123785/
https://www.ncbi.nlm.nih.gov/pubmed/35596202
http://dx.doi.org/10.1186/s13075-022-02795-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123785/
https://www.ncbi.nlm.nih.gov/pubmed/35596202
http://dx.doi.org/10.1186/s13075-022-02795-w

Ejemplares similares